Invesco Ltd. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 202 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$820,345
+16.1%
143,668
+1.9%
0.00%
Q1 2024$706,685
-45.7%
141,055
-2.5%
0.00%
Q4 2023$1,300,754
+24.1%
144,689
+7.2%
0.00%
Q3 2023$1,048,469
-14.3%
134,938
+6.7%
0.00%
Q2 2023$1,223,813
-11.9%
126,427
-0.2%
0.00%
Q1 2023$1,388,752
+289.3%
126,711
+53.4%
0.00%
Q4 2022$356,758
-46.4%
82,583
-6.6%
0.00%
Q3 2022$665,000
-23.4%
88,451
+2.3%
0.00%
Q2 2022$868,000
+114.3%
86,466
+164.0%
0.00%
Q1 2022$405,000
+55.2%
32,751
+187.0%
0.00%
Q4 2021$261,000
-19.4%
11,411
-22.0%
0.00%
Q3 2021$324,000
+39.1%
14,629
-18.6%
0.00%
Q2 2021$233,000
+385.4%
17,971
+69.9%
0.00%
Q4 2017$48,00010,5780.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 188,500$4,311,0003.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 334,500$7,647,0001.70%
IRONWOOD INVESTMENT MANAGEMENT LLC 131,760$3,013,0001.49%
NEA Management Company, LLC 3,069,834$70,207,0001.42%
Berry Street Capital Management LLP 575,000$13,151,0001.36%
Melqart Asset Management (UK) Ltd 916,321$20,956,0001.06%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$2,287,0000.93%
HighMark Wealth Management LLC 50,499$1,155,0000.73%
Artal Group S.A. 1,000,000$22,870,0000.62%
Vigilare Wealth Management 34,925$799,0000.47%
View complete list of AURINIA PHARMACEUTICALS INC shareholders